Baricitinib, Tildrakizumab-asmn, and Elagolix sodium. [electronic resource]

By: Contributor(s): Producer: 20190917Description: 685-688 p. digitalISSN:
  • 1544-3450
Subject(s): Online resources: In: Journal of the American Pharmacists Association : JAPhA vol. 58
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.